Centene lifts 2026 profit forecast, sees earnings growth continuing in 2027

October 27, 2026 6:20 AM EDT

U.S. dollar banknotes and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration

By Sneha S K and ‌Padmanabhan Ananthan

Oct 27 (Reuters) - ​Centene raised ​its annual profit forecast and said it expects 2027 earnings to be higher than this year, sending the health insurer's shares up 3%.

Higher medical costs ‌in recent years due to elevated healthcare demand have squeezed margins for health ⁠insurers and prompted them to improve pricing and tighten cost controls.

Centene has made great progress managing cost trends ‌and improving its cost structure, CEO ‌Sarah London said on a post-earnings call.

The company expects 2027 earnings to grow from both its updated baseline of $4.70 per share and its raised 2026 adjusted profit forecast ​of more than $5.20 per share.

Analysts expect a profit of $5.34 per share for 2027, as per data compiled by LSEG.

"Investors may appreciate the positive expected growth trajectory, despite the uncertainty ⁠around the important Medicaid market next year," said Morningstar analyst Julie Utterback.

The company has been facing Medicaid enrollment losses due ​to stricter eligibility rules, which have pushed some beneficiaries off coverage rolls, leaving insurers with a relatively sicker population that requires more medical care.

States ​are opting for a more methodical approach to eligibility ‌verifications, which should smooth membership impacts across 2027 and into early 2028, Centene said.

Centene said costs in its Medicaid plans for low-income individuals ⁠were in line with its expectations, in part due to higher reimbursement rates from states.

The company also said it was on track to break even in its Medicare Advantage business in 2026, a year ⁠ahead of expectations.

COSTS IN CHECK

Centene lowered its forecast for full-year medical cost ratio, a measure of premiums spent ​on medical care, to 90.4% to 91.1%, from 90.5% to 91.3% previously.

Its third-quarter medical cost ratio of 92.7%, which remained the same as last quarter, was also better than its expectations. Analysts had expected ‌a ratio of 92.84%.

The company benefited from improved pricing in its Obamacare plans, established under former President Barack Obama's Affordable Care Act, as ‌well as better performance in its Medicare Advantage plans for older Americans.

Centene reported third-quarter adjusted profit of ⁠58 cents per share. Excluding certain ‌severance costs, LSEG calculated adjusted ​profit at 16 cents per share, compared with analysts' average expectation of 10 cents.

(Reporting by Padmanabhan Ananthan and Sneha S K in Bengaluru; Editing by ‌Shinjini Ganguli)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters

Related Entities

Morningstar, Inc., Barack Obama, Earnings